Dexcom Inc 6340 Sequence Drsan Diego Ca 92121 Pma Numberp120005 Supplement Numbers090 Date Received10 14 2022 Decision Date01 12 2023 Product Code Mds Advisory Committee Clinical Chemistry Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Dexcom Inc 6340 Sequence Drsan Diego Ca 92121 Pma Numberp120005 Supplement Numbers090 Date Received10 14 2022 Decision Date01 12 2023 Product Code Mds Advisory Committee Clinical Chemistry Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
PMA P120005S090 DEXCOM, INC.6340 Sequence Drsan Diego, CA 92121 PMA NumberP120005 Supplement NumberS090 Date Received10/14/2022 Decision Date01/12/2023 Product Code MDS  Advisory Committee Clinical Chemistry Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No	DEXCOM G5 Mobile Continuous Glucose Monitoring System	2023-01-12